Home › Funds › Saturn V Capital Management LP › ZURA
Saturn V Capital Management LP position in ZURA
ZURA BIO LTD · Health Care
Saturn V Capital Management LP reported holding 2,032,454 shares of ZURA (ZURA BIO LTD) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.24% of its reported portfolio and ranking #19 among its reported holdings. Saturn V Capital Management LP has disclosed ZURA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Saturn V Capital Management LP's ZURA position evolved
Saturn V Capital Management LP first disclosed a stake in ZURA in Q1 2026 at 739,960 shares (US$4.4M). The position peaked in Q2 2026 at 2,101,119 shares, worth US$12.4M. Across 3 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,032,454 shares valued at US$8.5M — a reduction of -68,665 shares quarter over quarter.. Notable position changes include a 184% increase in Q2 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 739.96K | $4.40M | New |
| Q2 2026 | 2.10M | $12.40M | Add |
| Q3 2026 | 2.03M | $8.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO LTD) is a Health Care company. 43 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $55.71M · Q2 2026
- Venrock Adviser, LLC 6.43M sh · $37.97M · Q2 2026
- MPM BioImpact LLC 4.47M sh · $26.39M · Q2 2026
- GREAT POINT PARTNERS LLC 4.22M sh · $24.87M · Q2 2026
- BRAIDWELL LP 3.98M sh · $23.48M · Q2 2026
- Commodore Capital LP 3.25M sh · $19.18M · Q2 2026
- QVT Financial LP 1.90M sh · $11.18M · Q2 2026
- Ikarian Capital, LLC 1.22M sh · $7.19M · Q2 2026
- Boxer Capital Management, LLC 900.00K sh · $5.31M · Q2 2026
- Blue Owl Capital Holdings LP 735.00K sh · $3.06M · Q3 2026
- EcoR1 Capital, LLC 679.72K sh · $2.83M · Q3 2026
- Foresite Capital Management VI LLC 450.00K sh · $2.65M · Q2 2026
More on Saturn V Capital Management LP
FAQ
How long has Saturn V Capital Management LP held ZURA?
Saturn V Capital Management LP has disclosed ZURA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Saturn V Capital Management LP's current position in ZURA?
As of Q3 2026, Saturn V Capital Management LP holds 2.03M shares of ZURA (ZURA BIO LTD), valued at $8.46M, representing 1.24% of its reported portfolio and ranking #19.
Has Saturn V Capital Management LP been buying or selling ZURA?
In the latest 13F filing (Q3 2026), Saturn V Capital Management LP reduced its position in ZURA. The position peaked in Q2 2026 at 2.10M shares.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.